Return to Work in Younger Patients with Brain Metastases
Author Information
Author(s): Carsten Nieder, Siv Gyda Aanes, Luka Stanisavljevic, Bård Mannsåker, Ellinor Christin Haukland
Primary Institution: UiT The Arctic University of Norway
Hypothesis
What are the long-term outcomes and return to work rates in younger patients with brain metastases who survive for more than two years?
Conclusion
Many younger patients with brain metastases require multiple treatments, and few continue working long-term after their diagnosis.
Supporting Evidence
- 62 out of 455 patients survived for more than 2 years after treatment.
- Only 33% of patients who were working at diagnosis returned to work after 2 years.
- 19% of patients continued working in the long run.
Takeaway
This study looked at younger patients with brain cancer who lived for over two years and found that not many were able to keep working after their treatment.
Methodology
The study included patients who survived more than 2 years after treatment for brain metastases, analyzing their work status and outcomes.
Potential Biases
Referral bias is unlikely due to the study setting in a general oncology department.
Limitations
The study had a small sample size and lacked statistical power for detailed analyses.
Participant Demographics
The study included 15 women (54%) and 13 men (46%), aged 37-64 years, with a median age of 58.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website